The role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies.


Journal

Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965

Informations de publication

Date de publication:
17 12 2022
Historique:
entrez: 18 12 2022
pubmed: 19 12 2022
medline: 21 12 2022
Statut: epublish

Résumé

Pyrethroids and its derivatives widespread and uncontrolled continuous use has influenced multiple deleterious effects resulting in as a potential risk factor causing damage to the organ systems. Allethrin and prallethrin are extensively used yet their influences on human primary cells are very limited or under reported. The potential mechanisms by which allethrin and prallethrin modulates human primary cells, especially the molecular mechanisms or interconnectivity of autophagy-apoptosis, their clinical relevance in human subjects or patients are not well defined. In this current study, we've furnished the evidence that both allethrin and prallethrin user samples significantly induced Ccl2 mRNA expression, increased amount of reactive oxygen intermediate, inhibited membrane bound enzymes and altered membrane fluidity. Pyrethroid derivative users had induced levels of lipid peroxidation and induced binding activities of transcription factors(tfs) like CEBP-β and NF-AT. Pyrethroid derivatives induced autophagy, elicited intracellular Ca2+ concentration, calcineurin and regulated proapoptotic genes, DAPK1, Bim. Our current study presumably comprises the initial investigation of a very new mechanism of pyrethroid derivatives-moderated programed cell death in various cell sets or types, like human primary cells where-in this is a late event, is documented. Hence, current research-study might be significant in the various pyrethroid derivatives-allied hematological-related cancers and immunosuppressant or auto-immune disorders. In the foremost instance, we present data stating that pyrethroid derivatives induces multiple cell signaling cascades, like CEBP-β, NF-AT, ERK and MAPK having a role in autophagy thereby; synchronously effectively impact on the apoptosis, therefore causing hematological tumors and toxic or immune related disorders.

Identifiants

pubmed: 36528879
pii: 28328
doi: 10.18632/oncotarget.28328
pmc: PMC9760267
doi:

Substances chimiques

d,d-T80-prallethrin 23031-36-9
Allethrins 0
Insecticides 0
Pyrethrins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1323-1340

Références

Biochim Biophys Acta. 1978 Dec 15;515(4):367-94
pubmed: 365237
Cell. 2009 Jun 12;137(6):1001-4
pubmed: 19524504
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Mol Aspects Med. 2008 Feb-Apr;29(1-2):1-8
pubmed: 18037483
Structure. 2008 May;16(5):684-94
pubmed: 18462673
J Biol Chem. 2016 Jan 15;291(3):1481-91
pubmed: 26586913
J Cell Physiol. 2017 Dec;232(12):3598-3610
pubmed: 28128446
J Hazard Mater. 2021 Feb 5;403:123893
pubmed: 33264957
Int Arch Occup Environ Health. 2004 Jan;77(1):67-72
pubmed: 14551781
Toxicol In Vitro. 2014 Dec;28(8):1386-95
pubmed: 25072698
Vet Hum Toxicol. 1991 Jun;33(3):238-43
pubmed: 1713367
J Med Toxicol. 2010 Mar;6(1):27-30
pubmed: 20195813
FEBS J. 2010 Jan;277(1):48-57
pubmed: 19878313
Curr Stem Cell Res Ther. 2010 Mar;5(1):74-80
pubmed: 19951255
Int J Environ Res Public Health. 2012 Aug;9(8):2964-85
pubmed: 23066409
Annu Rev Entomol. 1998;43:1-16
pubmed: 9444749
Clin Chim Acta. 1971 Nov;35(1):73-8
pubmed: 5127008
Methods Enzymol. 1978;52:302-10
pubmed: 672633
Indian Pediatr. 2001 Feb;38(2):208
pubmed: 11224595
Chemosphere. 2003 May;51(6):475-80
pubmed: 12615099
Chemosphere. 2007 Apr;67(6):1065-71
pubmed: 17240419
PLoS One. 2017 Jan 18;12(1):e0169480
pubmed: 28099443
Food Chem Toxicol. 2004 May;42(5):697-706
pubmed: 15046814
Drug Metabol Drug Interact. 2008;23(3-4):211-36
pubmed: 19326768
Cell. 2002 Apr;109 Suppl:S67-79
pubmed: 11983154
Biochem Pharmacol. 2014 Apr 1;88(3):334-50
pubmed: 24522112
Cell. 2007 Jul 13;130(1):165-78
pubmed: 17632063
Biochem Mol Biol Int. 1995 Aug;36(6):1299-308
pubmed: 8535302
Cardiovasc Toxicol. 2022 May;22(5):462-476
pubmed: 35190965
Indian Pediatr. 2004 Nov;41(11):1177-8
pubmed: 15591679
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Arch Toxicol. 1989;63(1):54-8
pubmed: 2742502
Food Chem Toxicol. 2021 Jun;152:112162
pubmed: 33813062
Anticancer Agents Med Chem. 2016;16(11):1496-1510
pubmed: 27173965
J Neuroimmune Pharmacol. 2014 Jun;9(3):277-84
pubmed: 24277481
FASEB J. 2010 Aug;24(8):3052-65
pubmed: 20375270
J Bacteriol. 1969 Nov;100(2):914-22
pubmed: 4242923
J Biol Chem. 1959 Mar;234(3):466-8
pubmed: 13641241
Cell Signal. 1990;2(4):369-75
pubmed: 2174691
Toxicology. 2002 Feb 1;171(1):3-59
pubmed: 11812616
Int J Dev Neurosci. 2004 Feb;22(1):31-7
pubmed: 15013076
J Exp Clin Cancer Res. 2014 Dec 18;33:106
pubmed: 25519934
Blood. 1983 Jan;61(1):163-6
pubmed: 6681530
J Interferon Cytokine Res. 2009 Jun;29(6):313-26
pubmed: 19441883
Ann Agric Environ Med. 2016;23(1):106-10
pubmed: 27007526
Oncotarget. 2017 Apr 11;8(15):24119-24129
pubmed: 28445931
J Clin Invest. 1982 Jun;69(6):1384-7
pubmed: 6282935
J Innate Immun. 2013;5(4):401-13
pubmed: 23485819
J Anaesthesiol Clin Pharmacol. 2013 Jan;29(1):121-2
pubmed: 23494161
J Immunol. 2001 Apr 15;166(8):4949-57
pubmed: 11290773
Cell Tissue Res. 2012 Nov;350(2):361-72
pubmed: 22864983
Oncotarget. 2017 Jul 11;8(28):46663-46680
pubmed: 28445146
FEBS Lett. 2010 Apr 2;584(7):1287-95
pubmed: 20083114
BMC Clin Pathol. 2017 Aug 30;17:19
pubmed: 28860943
Eur J Cell Biol. 1995 Jan;66(1):3-14
pubmed: 7750517
ISRN Oncol. 2012;2012:137289
pubmed: 23119185
Cell Struct Funct. 1998 Feb;23(1):33-42
pubmed: 9639028
Environ Health Perspect. 2005 Feb;113(2):123-36
pubmed: 15687048
Chemosphere. 2008 Sep;73(3):360-4
pubmed: 18657844
PLoS One. 2014 Mar 05;9(3):e90563
pubmed: 24599185
Mutat Res. 2012 Aug 30;747(1):22-28
pubmed: 22475934
Biochim Biophys Acta. 1982 Jan 4;684(1):67-74
pubmed: 6120003
Biochim Biophys Acta. 1983 Feb;728(2):281-8
pubmed: 6219703
World Allergy Organ J. 2012 Jan;5(1):9-19
pubmed: 23268465

Auteurs

Jyothi Puvula (J)

Department of Biochemistry, Sri Krishnadevaraya University, Anantapuramu 515003, Andhra Pradesh, India.

Narendra Maddu (N)

Department of Biochemistry, Sri Krishnadevaraya University, Anantapuramu 515003, Andhra Pradesh, India.

Nagajothi Gutam (N)

Department Corporate Secretaryship-Biostatistics, Queen Mary's College, Chennai 600004, Tamil Nadu, India.

Asha Parimal (A)

School of Regenerative Medicine (SORM) - Manipal Academy of Higher Education, Deemed to be Manipal University, Bangalore 560065, Karnataka, India.

Pongali B Raghavendra (PB)

School of Regenerative Medicine (SORM) - Manipal Academy of Higher Education, Deemed to be Manipal University, Bangalore 560065, Karnataka, India.
National Institute of Biomedical Genomics, Kalyani 741251, West Bengal, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH